A Pilot Study To Define Chemical Coping in Cancer Patients Using the Delphi Method

Frequency, predictors, and outcomes of urine drug testing among patients with advanced cancer on chronic opioid therapy at an outpatient supportive care clinic

“…Also, a normal UDT result does not always rule out aberrant opioid use, because a common form of aberrant use is chemical coping. This is an inappropriate and/or excessive use of opioids to cope with the various stressful events associated with the diagnosis and management of cancer . The UDT results from such patients may be normal, thereby potentially conveying an erroneous message of appropriate opioid use.…”

“…This is an inappropriate and/or excessive use of opioids to cope with the various stressful events associated with the diagnosis and management of cancer. 16,[73][74][75][76] The UDT results from such patients may be normal, thereby potentially conveying an erroneous message of appropriate opioid use.…”

Predicting the risk for aberrant opioid use behavior in patients receiving outpatient supportive care consultation at a comprehensive cancer center

“…The SOAPP is a 14-item questionnaire that was designed to predict aberrant medication-related behaviors among patients with chronic pain, including those with cancer, [9][10][11][12] and the CAGE-AID questionnaire is used frequently to screen Cancer October 1, 2018 patients with cancer for alcoholism, chemical coping, and high expression of symptom distress. 8,[13][14][15][16] In the current study, our objective was to evaluate the utility of the SOAPP and CAGE-AID questionnaires for identifying patients who are at risk of aberrant opioid and drug use behaviors and to determine the optimal method for screening and managing future patients with cancer who are considered for opioid therapy. Therefore, our primary aim was to determine the frequency of risk and the factors predicting the risk of aberrant opioid and drug use behavior among patients with advanced cancer who undergo outpatient supportive care consultation at a comprehensive cancer center.…”

Addressing Opioid-Related Chemical Coping in Long-Term Opioid Therapy for Chronic Noncancer Pain: A Multicenter, Observational, Cross-Sectional Study

“…The spectrum of OUD in CNCP is wide and varies from opioid abuse to addiction [ 11 ]. Between these extremes, opioid-related chemical coping (OrCC) is the use of opioids to cope with emotional distress characterized by inappropriate and/or excessive opioid use [ 12 ]. OrCC should be distinguished from addiction, a brain disease that involves neuroplasticity and substantial loss of self-control [ 13 ].…”